Addressing STI challenges: A diagnostic update on the current landscape and future strategies.

The article focuses on addressing the challenges posed by the increasing rates of curable bacterial sexually transmitted infections (STIs) in the U.S. It mentions the current diagnostic landscape for STIs, including molecular technologies and point-of-care tests, the growing concern of antimicrobial resistance in STIs like Neisseria gonorrhoeae and Mycoplasma genitalium, and the importance of diagnostic stewardship in managing these infections effectively.